Intelligent Bio Solutions Inc.

NASDAQ:INBS

$5.52 USD

$0.52 (10.4%)

Volume
257.3K
Average Volume
3.52M
Market Capitalization
$11.86M
P/E Ratio
-0.03
Dividend Yield
0.00%
Price Target
$
Year High
$77.04
Year Low
$2.28
Payout Ratio
$0.00
Current Ratio
$0.57

Industry, Sector & symbol

Stock Exchange NASDAQ Capital Market
CEO Mr. Harry Simeonidis
Industry Diagnostics & Research
Sector Healthcare
Current Symbol INBS
CUSIP None
CIK 0001725430
Web https://gbs.inc
Phone 646 828 8258
Currency USD
Employees 51
Country US

Liquidity

Debt-to-Equity Ratio 0.33
Payout Ratio 0.00
Current Ratio 0.57
Quick Ratio 0.32
Cash Ratio 0.22

Sales & Book Value

Annual Sales $1.26M
Price / Sales 4.82
Cash Flow -86.38
Price / Cash Flow -1.73
Price / Book 0.13

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-10.58
Trailing P/E Ratio -0.03
PEG Ratio 0.00
P/E Growth 0.00
Net Income $-10.63M
Net Margin -544.54%
Pretax Margin -545.95%
Return on Equity -370.58%
Return on Assets -151.78%

Financials Score

AltmanZ Score -9.69
Piotroski Score 4.00
Working Capital -2.24M
Total Assets 8.83M
Ebit -9.6M
Market Cap 11.86M
Total Liabilities 5.67M

Poll Results

About Intelligent Bio Solutions Inc. (NASDAQ:INBS) Stock

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. ... is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024

2024-03-01 08:30:00

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on March 6, 2024. INBS will provide an update on the Company's growth and financial performance in 2023, among other topics.

Why Is Intelligent Bio Solutions (INBS) Stock Down 24% Today?

2024-02-12 09:01:14

Intelligent Bio Solutions (NASDAQ: INBS ) stock is falling on Monday following the release of the medical technology company's earnings report for its fiscal second quarter of 2024. The Intelligent Bio Solutions earnings release includes adjusted earnings per share of -$2.07.

Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023

2023-11-29 08:30:00

NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on December 7, 2023. The Company will provide insight into the Company's unique proprietary Intelligent Fingerprinting Drug Screening System, among other topics.

Why Is Intelligent Bio Solutions (INBS) Stock Down 48% Today?

2023-03-08 09:09:58

Intelligent Bio Solutions (NASDAQ: INBS ) stock is taking a beating on Wednesday after the company announced a proposed public stock offering. The company announced that offering yesterday, and then released details of the offering early this morning.

7 Penny Stocks To Watch With Big News In February; Time To Buy?

2023-02-07 09:12:37

Penny stocks to watch with news this month. The post 7 Penny Stocks To Watch With Big News In February; Time To Buy?

Frequently Asked Questions

What is the current Intelligent Bio Solutions Inc. (INBS) stock price?

Intelligent Bio Solutions Inc.(NASDAQ:INBS) stock price is $5.52 in the last trading session. During the trading session, INBS stock reached the peak price of $77.04 while $2.28 was the lowest point it dropped to. The percentage change in INBS stock occurred in the recent session was 10.4% while the dollar amount for the price change in INBS stock was $0.52.

INBS's industry and sector of operation?

The NASDAQ listed INBS is part of Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of INBS?

Mr. Harry Simeonidis | President & Chief Executive Officer
Ms. Victoria Gavrilenko | Operations Manager
Mr. Alex Arzeno | Vice President of Investor Relations
Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer
|

How many employees does INBS have?

Number of INBS employees currently stands at 51. INBS operates from 142 West 57th Street, New York, NY 10019, US.

Link for INBS official website?

Official Website of INBS is: https://gbs.inc

How do I contact INBS?

INBS could be contacted at phone #646 828 8258 and can also be accessed through its website. INBS operates from 142 West 57th Street, New York, NY 10019, US.

How many shares of INBS are traded daily?

The average number of INBS shares traded daily for last 3 months was 3.52M.

What is the market cap of INBS currently?

The market value of INBS currently stands at $11.86M with its latest stock price at $5.52